-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
M2 ion channel blocker
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1190215-03-2.gif)
| Category | Influenza Virus |
| CAS | 1190215-03-2 |
| Description | M2 ion channel blocker is an antiviral agent that works through blocking the activity of M2 ion channel. |
Product Information
| Synonyms | methyl(2S)-2-(1-adamantylmethylamino)-3-(1H-imidazol-5-yl)propanoate;1190215-03-2;CHEMBL2324198;SCHEMBL15029083;3801AH;W-6012; W 6012; W6012 |
| Molecular Weight | 317.43 |
| Molecular Formula | C18H27N3O2 |
| Canonical SMILES | COC(=O)C(CC1=CN=CN1)NCC23CC4CC(C2)CC(C4)C3 |
| InChI | InChI=1S/C18H27N3O2/c1-23-17(22)16(5-15-9-19-11-21-15)20-10-18-6-12-2-13(7-18)4-14(3-12)8-18/h9,11-14,16,20H,2-8,10H2,1H3,(H,19,21)/t12?,13?,14?,16-,18?/m0/s1 |
| InChIKey | GCZFPPAFJOOMRO-IEKYFPHUSA-N |
| Purity | 95% |
| Solubility | 10 mM in DMSO |
| Appearance | Powder |
| Application | M2 ion channel blocker is an antiviral agent that works through blocking the activity of M2 ion channel. |
| Shelf Life | As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly |
| Storage | -20°C Freeze |
| Complexity | 487 |
| Exact Mass | 317.21032711 |
| PSA | 63.05000 |
| Target | Influenza Virus |
| XLogP3-AA | 2.3 |
